Literature DB >> 27311713

Structural Basis for the Specific Recognition of RhoA by the Dual GTPase-activating Protein ARAP3.

Hongyu Bao1, Fudong Li1, Chongyuan Wang1, Na Wang1, Yiyang Jiang1, Yajun Tang1, Jihui Wu2, Yunyu Shi3.   

Abstract

ARAP3 (Arf-GAP with Rho-GAP domain, ANK repeat, and PH domain-containing protein 3) is unique for its dual specificity GAPs (GTPase-activating protein) activity for Arf6 (ADP-ribosylation factor 6) and RhoA (Ras homolog gene family member A) regulated by phosphatidylinositol 3,4,5-trisphosphate and a small GTPase Rap1-GTP and is involved in regulation of cell shape and adhesion. However, the molecular interface between the ARAP3-RhoGAP domain and RhoA is unknown, as is the substrates specificity of the RhoGAP domain. In this study, we solved the crystal structure of RhoA in complex with the RhoGAP domain of ARAP3. The structure of the complex presented a clear interface between the RhoGAP domain and RhoA. By analyzing the crystal structure and in combination with in vitro GTPase activity assays and isothermal titration calorimetry experiments, we identified the crucial residues affecting RhoGAP activity and substrates specificity among RhoA, Rac1 (Ras-related C3 botulinum toxin substrate 1), and Cdc42 (cell division control protein 42 homolog).
© 2016 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  ARAP3; GTPase activity assay; GTPase-activating protein (GAP); Ras homolog gene family, member A (RhoA); Rho (Rho GTPase); RhoGAP; complex; crystal structure; substrate specificity

Mesh:

Substances:

Year:  2016        PMID: 27311713      PMCID: PMC4974384          DOI: 10.1074/jbc.M116.736140

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  43 in total

1.  ARAP1: a point of convergence for Arf and Rho signaling.

Authors:  Koichi Miura; Kerry M Jacques; Stacey Stauffer; Atsutaka Kubosaki; Kejin Zhu; Dianne Snow Hirsch; James Resau; Yi Zheng; Paul A Randazzo
Journal:  Mol Cell       Date:  2002-01       Impact factor: 17.970

Review 2.  Requirement for Arf6 in cell adhesion, migration, and cancer cell invasion.

Authors:  Hisataka Sabe
Journal:  J Biochem       Date:  2003-10       Impact factor: 3.387

Review 3.  The Rho family of small GTPases: crucial regulators of skeletal myogenesis.

Authors:  B A Bryan; D Li; X Wu; M Liu
Journal:  Cell Mol Life Sci       Date:  2005-07       Impact factor: 9.261

Review 4.  Regulation of small GTPases by GEFs, GAPs, and GDIs.

Authors:  Jacqueline Cherfils; Mahel Zeghouf
Journal:  Physiol Rev       Date:  2013-01       Impact factor: 37.312

5.  Control of neurite outgrowth by RhoA inactivation.

Authors:  Chan-Young Jeon; Mi-Young Moon; Jong-Hyun Kim; Hee-Jun Kim; Jae-Gyu Kim; Yi Li; Jae-Kwang Jin; Pyeung-Hyeun Kim; Hyoung-Chun Kim; Kathryn E Meier; Yong-Sun Kim; Jae-Bong Park
Journal:  J Neurochem       Date:  2011-11-24       Impact factor: 5.372

6.  Features and development of Coot.

Authors:  P Emsley; B Lohkamp; W G Scott; K Cowtan
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2010-03-24

7.  Small GTPase Rap1 regulates cell migration through regulation of small GTPase RhoA activity in response to transforming growth factor-β1.

Authors:  Mi-Young Moon; Hee-Jun Kim; Jae-Gyu Kim; Jae-Yong Lee; Jaebong Kim; Sung-Chan Kim; Ihn-Geun Choi; Pyeung-Hyeun Kim; Jae-Bong Park
Journal:  J Cell Physiol       Date:  2013-11       Impact factor: 6.384

8.  Phospholipids can switch the GTPase substrate preference of a GTPase-activating protein.

Authors:  Erzsébet Ligeti; Marie-Claire Dagher; Samuel E Hernandez; Anthony J Koleske; Jeffrey Settleman
Journal:  J Biol Chem       Date:  2003-12-29       Impact factor: 5.157

9.  MgF(3)(-) as a transition state analog of phosphoryl transfer.

Authors:  Debbie L Graham; Peter N Lowe; Geoffrey W Grime; Michael Marsh; Katrin Rittinger; Stephen J Smerdon; Steven J Gamblin; John F Eccleston
Journal:  Chem Biol       Date:  2002-03

10.  Phaser crystallographic software.

Authors:  Airlie J McCoy; Ralf W Grosse-Kunstleve; Paul D Adams; Martyn D Winn; Laurent C Storoni; Randy J Read
Journal:  J Appl Crystallogr       Date:  2007-07-13       Impact factor: 3.304

View more
  5 in total

1.  Covalent Inhibitors Allosterically Block the Activation of Rho Family Proteins and Suppress Cancer Cell Invasion.

Authors:  Zhongya Sun; Hao Zhang; Yuanyuan Zhang; Liping Liao; Wen Zhou; Fengcai Zhang; Fulin Lian; Jing Huang; Pan Xu; Rukang Zhang; Wenchao Lu; Mingrui Zhu; Hongru Tao; Feng Yang; Hong Ding; Shijie Chen; Liyan Yue; Bing Zhou; Naixia Zhang; Minjia Tan; Hualiang Jiang; Kaixian Chen; Bo Liu; Chuanpeng Liu; Yongjun Dang; Cheng Luo
Journal:  Adv Sci (Weinh)       Date:  2020-05-13       Impact factor: 16.806

2.  Integrative genomic analysis identifies associations of molecular alterations to APOBEC and BRCA1/2 mutational signatures in breast cancer.

Authors:  Victor Trevino
Journal:  Mol Genet Genomic Med       Date:  2019-07-11       Impact factor: 2.183

Review 3.  MicroRNA Regulation of the Small Rho GTPase Regulators-Complexities and Opportunities in Targeting Cancer Metastasis.

Authors:  Brock A Humphries; Zhishan Wang; Chengfeng Yang
Journal:  Cancers (Basel)       Date:  2020-04-28       Impact factor: 6.639

4.  RACGAP1 variants in a sporadic case of CDA III implicate the dysfunction of centralspindlin as the basis of the disease.

Authors:  Sandeep N Wontakal; Mishan Britto; Huan Zhang; Yongshuai Han; Chengjie Gao; Sarah Tannenbaum; Benjamin H Durham; Margaret T Lee; Xiuli An; Masanori Mishima
Journal:  Blood       Date:  2022-03-03       Impact factor: 22.113

5.  RGS3L allows for an M2 muscarinic receptor-mediated RhoA-dependent inotropy in cardiomyocytes.

Authors:  Susanne Lutz; Thomas Wieland; Magdolna K Levay; Kurt A Krobert; Andreas Vogt; Atif Ahmad; Andreas Jungmann; Christiane Neuber; Sebastian Pasch; Arne Hansen; Oliver J Müller
Journal:  Basic Res Cardiol       Date:  2022-03-01       Impact factor: 12.416

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.